# Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic Hyperplasia

> **NCT02639442** · NA · COMPLETED · sponsor: **ProArc Medical** · enrollment: 29 (actual)

## Conditions studied

- Benign ProstaticHyperplasia (BPH)

## Interventions

- **DEVICE:** ClearRing™

## Key facts

- **NCT ID:** NCT02639442
- **Lead sponsor:** ProArc Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2018-06
- **Final completion:** 2019-05
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2023-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02639442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02639442, "Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02639442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*